Determine the necessary mass, volume, or concentration for preparing a solution.
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
Information
Lazertinib (YH25448,GNS-1480) is a potent, highly mutant-selective and irreversibleEGFR-TKIwith IC50 values of 1.7 nM, 2 nM, 5 nM, 20.6 nM and 76 nM for Del19/T790M, L858R/T790M, Del19, L85R and Wild type EGFR respectively, showing much higher IC50 values aganist ErbB2 and ErbB4.
Targets
Del19/T790M (Cell-free assay); L858R/T790M EGFR (Cell-free assay); Del19 (Cell-free assay); L85R (Cell-free assay); WT EGFR (Cell-free assay) 1.7 nM; 2 nM; 5 nM; 20.6 nM; 76 nM
In vitro
Lazertinib targets the activating EGFR mutations Del19 and L858R, as well as the T790M mutation, while sparing wild type. In NSCLC cell lines and primary cancer cells from patients harboring EGFR mutations, YH25448 more potently inhibits cancer cell growth and significantly increases tumor cell apoptosis compared to osimertinib. In the cell proliferation assays, GI50 values of lazertinib are 6 nM, 5 nM, and 711 nM for H1975 cells (L858R/T790M), PC9 cells (del19) and H2073 cells (wt), respectively.
In vivo
In an in vivo mouse model implanted with H1975 cells, once-daily YH25448 treatment results in indramatic dose-dependent tumor regression in both subcutaneous and intracranial lesions with no abnormal signs such as skin keratosis. The plasma half-life of YH25448 is 5.9-6.8 hr, while the tumor to plasma AUC0-last ratio is 3.0-5.1 in tumor-bearing mice. YH25448 shows excellent penetration of the blood-brain bartier, achieving CSF concentrations exceeding the IC50 value for pEGFR inhibition. YH25448 shows superior efficacy for tumor regression in an EGFR mutant brain metastasis model.
Cell Research(from reference)
Cell lines:Ba/F3 cells
Concentrations:5, 10, 100 nM
Incubation Time:6 h
Taxonomy Tree
| Kingdom | Organic compounds |
|---|---|
| Superclass | Organoheterocyclic compounds |
| Classe | Oxazinanes |
| Subclass | Morpholines |
| Intermediate Tree Nodes | Not available |
| Direct Parent | Phenylmorpholines |
| Alternative Parents | Phenylpyrazoles 2'-Aminoanilides Methoxyanilines Aminophenyl ethers Phenoxy compounds N-arylamides Methoxybenzenes Dialkylarylamines Anisoles Aralkylamines Aminopyrimidines and derivatives Alkyl aryl ethers Heteroaromatic compounds Acrylic acids and derivatives Trialkylamines Secondary carboxylic acid amides Amino acids and derivatives Secondary amines Oxacyclic compounds Dialkyl ethers Azacyclic compounds Organopnictogen compounds Organic oxides Hydrocarbon derivatives Carbonyl compounds |
| Molecular Framework | Aromatic heteromonocyclic compounds |
| Substituents | Phenylmorpholine - Phenylpyrazole - 2'-aminoanilide - Aminophenyl ether - Methoxyaniline - Anilide - Phenoxy compound - Methoxybenzene - Aniline or substituted anilines - Dialkylarylamine - N-arylamide - Tertiary aliphatic/aromatic amine - Phenol ether - Anisole - Aralkylamine - Aminopyrimidine - Alkyl aryl ether - Benzenoid - Pyrimidine - Monocyclic benzene moiety - Acrylic acid or derivatives - Heteroaromatic compound - Pyrazole - Azole - Tertiary aliphatic amine - Tertiary amine - Secondary carboxylic acid amide - Carboxamide group - Amino acid or derivatives - Oxacycle - Azacycle - Secondary amine - Ether - Dialkyl ether - Carboxylic acid derivative - Organic nitrogen compound - Organic oxygen compound - Organopnictogen compound - Organic oxide - Hydrocarbon derivative - Organooxygen compound - Organonitrogen compound - Carbonyl group - Amine - Aromatic heteromonocyclic compound |
| Descrição | This compound belongs to the class of organic compounds known as phenylmorpholines. These are aromatic compounds containing a morpholine ring and a benzene ring linked to each other through a CC or a CN bond. |
| External Descriptors | Not available |
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Find and download the COA for your product by matching the lot number on the packaging.
| Lot Number | Certificate Type | Data | Item |
|---|---|---|---|
| Certificate of Analysis | Sep 04, 2025 | L414136 | |
| Certificate of Analysis | Sep 04, 2025 | L414136 | |
| Certificate of Analysis | Sep 04, 2025 | L414136 | |
| Certificate of Analysis | Sep 04, 2025 | L414136 | |
| Certificate of Analysis | Sep 04, 2025 | L414136 | |
| Certificate of Analysis | Sep 04, 2025 | L414136 | |
| Certificate of Analysis | Sep 20, 2022 | L414136 | |
| Certificate of Analysis | Sep 20, 2022 | L414136 | |
| Certificate of Analysis | Sep 20, 2022 | L414136 |
| Solubilidade | Solubility (25°C) In vitro DMSO: 4 mg/mL (7.21 mM); Water: Insoluble; Ethanol: Insoluble; |
|---|---|
| DMSO (mg/mL) Solubilidade máxima | 4 |
| DMSO (mM) Solubilidade máxima | 7.21184929917773 |
| Água (mg/mL) Solubilidade máxima | <1 |
| Peso molecular | 554.6 |
| XLogP3 | 3.400 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 10 |
| Exact Mass | 554.275 Da |
| Monoisotopic Mass | 554.275 Da |
| Topological Polar Surface Area | 110.000 Ų |
| Heavy Atom Count | 41 |
| Formal Charge | 0 |
| Complexity | 837.000 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| The total count of all stereochemical bonds | 0 |
| Covalently-Bonded Unit Count | 1 |
H302:Harmful if swallowed
H317:May cause an allergic skin reaction
H361:Suspected of damaging fertility or the unborn child
H372:Causes damage to organs through prolonged or repeated exposure
P260:Do not breathe dust/fume/gas/mist/vapors/spray.
P261:Avoid breathing dust/fume/gas/mist/vapors/spray.
P264:Wash hands [and …] thoroughly after handling.
P270:Do not eat, drink or smoke when using this product.
P272:Contaminated work clothing should not be allowed out of the workplace.
P280:Wear protective gloves/protective clothing/eye protection/face protection.
P321:Specific treatment (see ... on this label).
P330:Rinse mouth.
P302+P352:IF ON SKIN: wash with plenty of water.
P333+P313:IF SKIN irritation or rash occurs: Get medical advice/attention.
P362+P364:Take off contaminated clothing and wash it before reuse.
P405:Store locked up.
P501:Dispose of contents/container to an approved waste disposal plant.
P203:Obtain, read and follow all safety instructions before use.
P301+P317:IF SWALLOWED: Get medical help.
P318:if exposed or concerned, get medical advice.
P319:Get medical help if you feel unwell.
Validated application protocols (e.g., specific assay formats, concentrations, or cell models) are not provided in the Product Data for this SKU.
General guidance for small-molecule tool compounds:
These suggestions are general, literature-informed practices and are not validated for this specific lot or item.
This product is a research-use small molecule often employed as a biochemical tool compound in kinase-focused studies. Item-specific biological data are not provided; the context below is based on general literature about this scaffold class and should not be construed as a specification or clinical claim.
Important: No therapeutic, diagnostic, or clinical uses are claimed or supported. Use solely as a research tool under appropriate institutional oversight.
Lazertinib is not a buffering reagent. It does not form conventional laboratory buffer systems.
Practical notes for assay buffers (general, for small-molecule bioassays):
For experiments requiring sustained exposure, confirm stability in the chosen buffer over time (bench-top and 37°C), and assess adsorption to plastics versus glassware.
As a bioactive screening compound, Lazertinib itself is not replaceable by a “green” alternative without altering biological activity. However, greener practices can be applied to its handling and analytics.
Greener solvent and workflow choices (general guidance):
Illustrative comparison (general, non-item-specific):
Note: Any solvent change must ensure compound integrity and assay performance; confirm by stability screening and recovery checks.
No pharmaceutical or therapeutic claims are made for this product. It is provided strictly for research use only.
Relevant research-oriented, non-clinical uses:
Regulatory/compendial status:
Item-specific physicochemical specifications have not been provided in the Product Data and should be confirmed on the CoA/Spec Sheet for this SKU.
Practical notes (general, literature-informed):
What Moligand™ typically implies (general quality principles):
Stabilizers/additives:
Documentation and verification:
This product is supplied as a finished, bioactive small molecule for research screening and assay development. It is not typically employed as a reagent or building block in synthetic transformations.
For laboratories performing analytical method development:
No named synthetic reactions or catalyst systems are typically associated with using Lazertinib as a reagent.
Not applicable. Lazertinib is not provided as a reagent for performing chemical reactions, and no item-specific reaction conditions are relevant.
Analytical and handling conditions (general, for context):
These are general laboratory practices and do not constitute specifications for this item.
Safety classification is not specified in the Product Data. Always consult the SDS for authoritative information before use.
Note: This product is for research use only.
Lazertinib is supplied for research screening; item-specific solubility is not provided. The following guidance reflects common practice for hydrophobic kinase inhibitors (general, literature-informed):
Small comparison (general):
Always verify absence of precipitation after dilution; if needed, sonicate briefly and use microfilters before dosing.
Note: For research use only; not for human or veterinary use.
Lazertinib is supplied as a research-use small molecule (Moligand series). Structural identifiers for this catalog item are limited in the Product Data; key registry numbers are provided below.
General structural description (literature, for context only):
Notes:
Lazertinib is supplied as a finished bioactive compound, not as a synthetic intermediate. It is generally not used as a reagent or synthon in preparative organic chemistry.
If derivatization is pursued for probe development (general considerations):
For most laboratories, the practical “utility” of this product lies in its role as a well-characterized screening compound rather than as a building block.
Target specificity data (e.g., primary target, binding constants, selectivity panels) are not provided in the Product Data for this SKU.
O nosso guia de seleção de graus abrange pureza, estado do estabilizador e adequação à aplicação para todas as variantes do nosso catálogo.
Ver o guia de graus Moligand™ →